Literature DB >> 16705182

Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration.

Keun-A Chang1, Hye-Sun Kim, Tae-Young Ha, Ji-Won Ha, Ki Young Shin, Yun Ha Jeong, Jean-Pyo Lee, Cheol-Hyoung Park, Seonghan Kim, Tae-Kyoung Baik, Yoo-Hun Suh.   

Abstract

Amyloid precursor protein (APP) has eight potential phosphorylation sites in its cytoplasmic domain. Recently, it has demonstrated that the constitutive phosphorylation of APP at T668 (APP695 isoform numbering) was observed specifically in the brain. Neuron-specific phosphorylation of APP at T668 is thought to be important for neuronal functions of APP, although its exact physiological significance remains to be clarified. In this study, we show that the phosphorylation of the APP intracellular domain (AICD) at T668 is essential for its binding to Fe65 and its nuclear translocation and affects the resultant neurotoxicity, possibly mediated through the induction of glycogen synthase kinase 3beta and tau phosphorylation by enhancing the formation of a ternary complex with Fe65 and CP2 transcription factor. Taken together, these results suggest that the phosphorylation of AICD at T668 contributes to the neuronal degeneration in Alzheimer's disease (AD) by regulating its translocation into the nucleus and then affects neurodegeneration; therefore, the specific inhibitor of T668 phosphorylation might be the target of AD therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705182      PMCID: PMC1489099          DOI: 10.1128/MCB.02393-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  The Role of presenilins in gamma-secretase activity.

Authors:  M S Wolfe; C Haass
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

2.  Phosphorylation-induced structural changes in the amyloid precursor protein cytoplasmic tail detected by NMR.

Authors:  T A Ramelot; L K Nicholson
Journal:  J Mol Biol       Date:  2001-03-30       Impact factor: 5.469

3.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.

Authors:  X Cao; T C Südhof
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

4.  The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.

Authors:  W T Kimberly; J B Zheng; S Y Guénette; D J Selkoe
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

Review 5.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

6.  The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene.

Authors:  N Zambrano; P Bruni; G Minopoli; R Mosca; D Molino; C Russo; G Schettini; M Sudol; T Russo
Journal:  J Biol Chem       Date:  2001-02-21       Impact factor: 5.157

7.  Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.

Authors:  K Iijima; K Ando; S Takeda; Y Satoh; T Seki; S Itohara; P Greengard; Y Kirino; A C Nairn; T Suzuki
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

8.  Phosphorylation of thr(668) in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3).

Authors:  C L Standen; J Brownlees; A J Grierson; S Kesavapany; K F Lau; D M McLoughlin; C C Miller
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

9.  Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid.

Authors:  K Ando; K I Iijima; J I Elliott; Y Kirino; T Suzuki
Journal:  J Biol Chem       Date:  2001-08-21       Impact factor: 5.157

Review 10.  Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's beta-amyloid precursor protein.

Authors:  T Russo; R Faraonio; G Minopoli; P De Candia; S De Renzis; N Zambrano
Journal:  FEBS Lett       Date:  1998-08-28       Impact factor: 4.124

View more
  55 in total

1.  The amyloid-beta precursor protein is phosphorylated via distinct pathways during differentiation, mitosis, stress, and degeneration.

Authors:  Zoia Muresan; Virgil Muresan
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

Review 2.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

3.  Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

Authors:  Shiyong Peng; Diego J Garzon; Monica Marchese; William Klein; Stephen D Ginsberg; Beverly M Francis; Howard T J Mount; Elliott J Mufson; Ahmad Salehi; Margaret Fahnestock
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

4.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

5.  Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells.

Authors:  Karla M Acevedo; Carlos M Opazo; David Norrish; Leesa M Challis; Qiao-Xin Li; Anthony R White; Ashley I Bush; James Camakaris
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

6.  Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain.

Authors:  Fabian M Nensa; Martin H D Neumann; Andreas Schrötter; Andre Przyborski; Thomas Mastalski; Sergej Susdalzew; Christina Looβe; Stefan Helling; Fouzi El Magraoui; Ralf Erdmann; Helmut E Meyer; Julian Uszkoreit; Martin Eisenacher; Jaehong Suh; Suzanne Y Guénette; Nelli Röhner; Donat Kögel; Carsten Theiss; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2013-11-27       Impact factor: 5.911

7.  Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.

Authors:  Carolyn L Fisher; Ross J Resnick; Soumya De; Lucila A Acevedo; Kun Ping Lu; Frank C Schroeder; Linda K Nicholson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

Review 9.  Docosahexaenoic acid (DHA) and hepatic gene transcription.

Authors:  Donald B Jump; Daniela Botolin; Yun Wang; Jinghua Xu; Olivier Demeure; Barbara Christian
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

10.  S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model.

Authors:  Tae-Young Ha; Keun-A Chang; Jeong a Kim; Hye-Sun Kim; Seonghan Kim; Young Hae Chong; Yoo-Hun Suh
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.